142 related articles for article (PubMed ID: 353124)
1. [Chemotherapy in curable breast cancer].
Seradour B; Thomas M
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
[No Abstract] [Full Text] [Related]
2. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
3. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
4. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K; Lippman M
Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
[No Abstract] [Full Text] [Related]
5. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.
Weiss RB; DeVita VT
Surg Gynecol Obstet; 1979 Aug; 149(2):267-71. PubMed ID: 380029
[No Abstract] [Full Text] [Related]
6. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
[No Abstract] [Full Text] [Related]
8. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
9. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey D; Gelman R; Falkson G
Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
[No Abstract] [Full Text] [Related]
10. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR
Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for breast cancer.
Sarg MJ
J Reprod Med; 1979 Jul; 23(1):3-11. PubMed ID: 226698
[No Abstract] [Full Text] [Related]
12. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Rabinovich MG; Leone BA; Landó O
Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
[No Abstract] [Full Text] [Related]
13. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Chlebowski RT
J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336
[No Abstract] [Full Text] [Related]
14. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
[TBL] [Abstract][Full Text] [Related]
15. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
16. Occasional notes. The management of early breast cancer.
Canellos GP; Hellman S; Veronesi U
N Engl J Med; 1982 Jun; 306(23):1430-2. PubMed ID: 7043266
[No Abstract] [Full Text] [Related]
17. Are surgical adjuvant trials altering the course of breast cancer?
Bonadonna G; Valagussa P; Rossi A; Zucali R; Tancini G; Bajetta E; Brambilla C; De Lena M; Di Fronzo G; Banfi A; Rilke F; Veronesi U
Semin Oncol; 1978 Dec; 5(4):450-64. PubMed ID: 366757
[No Abstract] [Full Text] [Related]
18. [Results of "5-drug" treatment of advanced breast cancer].
Dorociak R
Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
[No Abstract] [Full Text] [Related]
19. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
García Puche JL; Ballesteros P; Cueto J; Mendiola C; Rodríguez PA; Talavera MC
Rev Clin Esp; 1979 Feb; 152(3):203-8. PubMed ID: 441472
[No Abstract] [Full Text] [Related]
20. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
